XML 56 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 6 - Stock-Based Compensation and Preferred Stock
12 Months Ended
Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 6 – Stock-Based Compensation and Preferred Stock


Plan Information


The 1998 Incentive Stock Plan (the “Plan”) provides for awards of stock options and restricted stock to officers, directors, key employees and consultants.  The Plan provides that upon any issuance of additional shares of common stock by the Company, other than pursuant to the Plan, the number of shares covered by the Plan will increase to an amount equal to 10% of the then outstanding shares of common stock.  Under the Plan, option prices will be set by the Board of Directors and may be greater than, equal to, or less than fair market value on the grant date.


At September 30, 2013, 1,024,656 shares of common stock were reserved for the exercise of, or lapse of restrictions on, stock awards under the Plan.  Of these reserved shares, 280,141 shares were available for future grants.


Stock Options


Share-based payments to employees, including grants of employee stock options, are recognized in financial statements based on their grant date fair value over the requisite service period. Compensation expense for stock-based awards is included in the operating, selling, general and administrative expense section of the consolidated statements of income and comprehensive income.


Stock options are valued at the date of the award, which does not precede the approval date, and compensation cost is recognized on a straight-line basis over the vesting period. Stock options granted to employees generally become exercisable over a four or five-year period from the date of grant and generally expire ten years after the date of grant. Stock options granted to the Board of Directors generally become exercisable on the date of grant and generally expire ten years after the date of grant.


A summary of the status of the Company's stock options at September 30, 2013 and changes during the year then ended is presented below:


   

Options

   

Weighted

Average

Exercise

Price

   

Aggregate

Intrinsic

Value

 

Outstanding at September 30, 2012

    370,000     $ 2.83          

Granted

    30,000     $ 2.33          

Exercised

    (2,000 )   $ 1.65     $ 940  

Expired

 

    $

         

Forfeited

    (35,000 )   $ 2.43          

Outstanding at September 30, 2013

    363,000     $ 2.83     $ 0  

Exercisable at September 30, 2013

    163,000     $ 3.30     $ 0  

The total intrinsic value of options exercised was $940, $2,640, and $5,670 for the years ended September 30, 2013, 2012 and 2011, respectively.  


Information about the Company’s outstanding and exercisable stock options at September 30, 2013 is as follows:


 

Exercise Price

   

Stock Options

Outstanding

   

Exercisable

Stock Options

Outstanding

 

Remaining

Contractual

Life (years)

  $ 2.450       250,000       50,000  

8.5

  $ 3.001       65,000       65,000  

4.9

  $ 3.450       15,000       15,000  

3.4

  $ 5.780       15,000       15,000  

2.4

  $ 4.620       15,000       15,000  

1.4

  $ 4.400       3,000       3,000  

0.4

            363,000       163,000    

The Company granted nonqualified stock options totaling 30,000 shares and 250,000 shares for fiscal years ended September 30, 2013 and 2012, respectively. No nonqualified stock options were granted in fiscal year 2011. The Company estimated the fair value of the options granted using the Black-Scholes option valuation model and the assumptions shown in the table below. The Company estimated the expected term of options granted based on the historical grants and exercises of the Company's options. The Company estimated the volatility of its common stock at the date of the grant based on both the historical volatility as well as the implied volatility on its common stock. The Company based the risk-free rate that was used in the Black-Scholes option valuation model on the implied yield in effect at the time of the option grant on U.S. Treasury zero-coupon issues with equivalent expected terms. The Company has never paid cash dividends on its common stock and does not anticipate paying any cash dividends in the foreseeable future. Consequently, the Company used an expected dividend yield of zero in the Black-Scholes option valuation model. The Company amortizes the resulting fair value of the options ratably over the vesting period of the awards. The Company used historical data to estimate the pre-vesting options forfeitures and records share-based expense only for those awards that are expected to vest.


The estimated fair value at date of grant for stock options utilizing the Black-Scholes option valuation model and the assumptions that were used in the Black-Scholes option valuation model for the fiscal years 2013 and 2012 stock option grants are as follows:


   

2013

   

2012

 

Estimated fair value of options at grant date

  $ 29,040     $ 267,925  

Black-Scholes model assumptions:

               

Average expected life (years)

    6       6  

Average expected volatility factor

    41 %     41 %

Average risk-free interest rate

    2.95 %     2.99 %

Average expected dividends yield

 

   

 

Compensation expense related to stock options recorded for the years ended September 30, 2013, 2012 and 2011 is as follows:


   

2013

   

2012

   

2011

 

Fiscal year 2008 grant

  $

    $ 3,562     $ 10,349  

Fiscal year 2012 grant

    95,560       61,176    

 

Fiscal year 2013 grant

    1,481    

   

 
                         

Total compensation expense

  $ 97,041     $ 64,738     $ 10,349  

The Company records compensation expense over the vesting term of the related options. At September 30, 2013, compensation costs related to these unvested stock options not yet recognized in the statements of income and comprehensive income was $111,189.


Restricted stock


The Company granted restricted stock in March 2013 and 2012 to its Board of Directors totaling 31,815 shares and 31,969 shares, respectively, and in March and May 2011 to its Board of Directors and certain employees totaling 58,920 shares. The restricted stock grants were valued at market value on the date of grant. The restricted shares are delivered to the directors and employees at the end of the 12 month holding period. The fair value of the shares upon issuance totaled $70,000, $70,000 and $170,000 for the 2013, 2012 and 2011 fiscal year grants, respectively. The grants are amortized over the 12 month holding period as compensation expense. Compensation expense related to restricted stock recorded for the years ended September 30, 2013, 2012 and 2011 is as follows:


   

2013

   

2012

   

2011

 

Fiscal year 2010 grant

  $

    $

    $ 25,000  

Fiscal year 2011 grant

 

      95,833       74,167  

Fiscal year 2012 grant

    29,167       40,833    

 

Fiscal year 2013 grant

    40,833    

   

 
                         
    $ 70,000     $ 136,666     $ 99,167